

Fundamental dimension Equity attribute | TRILeader $108.23▼-0.72% Cap $46.89BP/E 28.9x QuantScore60/100 | EXPGYPeer $41.35▼-0.05% Cap $36.58BP/E 25.2x QuantScore60/100 | IFPJFPeer $11.640.00% Cap $15.81BP/E 49.0x QuantScore48/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
93/100 |
73/100 |
62/100 |
Valuation Multiples, PEG & DCF upside | 65/100 | 75/100 | 82/100 |
Health Piotroski, Altman Z, leverage & liquidity | 64/100 | 55/100 | 34/100 |
Growth Revenue / earnings growth & margins | 30/100 | 34/100 | 27/100 |
Sentiment Analyst ratings, targets & revisions | 48/100 | 61/100 | 33/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 28.9x | 25.2x | 49.0x |
Forward P/E (next FY) | 24.7x | 20.5x | 20.8x |
EV / EBITDA (TTM) | 15.0x | 13.5x | 11.8x |
Price / Sales | 6.0x | 4.3x | 2.8x |
Price / Free Cash Flow | 21.2x | 16.9x | 13.4x |
PEG ratio | 6.93 | 0.84 | 0.44 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 7 / 9 | 7 / 9 | 7 / 9 |
Altman Z-Score | 5.50 (Safe) | 5.62 (Safe) | 1.62 (Distress) |
Total debt / equity | 0.29 | 1.00 | 0.65 |
Quick ratio | 0.5x | 0.9x | 0.5x |
Interest coverage | 12.8x | 9.9x | 4.6x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +3.0% | +12.6% | +13.7% |
Net income growth YoY | -32.0% | +29.2% | -96.3% |
Gross margin (TTM) | 66.5% | 25.3% | 18.8% |
Operating margin (FY) | 26.6% | 25.4% | 19.6% |
FCF margin (FY) | 27.5% | 25.9% | 21.5% |
5. Trailing price performancePrice change over period |
1M return | +14.7% | +16.6% | -2.7% |
3M return | +12.5% | +17.0% | -0.6% |
6M return | +16.4% | +11.0% | +7.0% |
Year to date | -19.2% | -8.5% | -3.0% |
1Y return | -33.8% | -14.7% | -5.3% |
3Y return | -13.1% | +26.4% | +30.9% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $156.30 +44.4% upside | $34.66 -16.2% premium | $27.57 +136.9% upside |
Wall Street consensus target | $128.60 +18.8% · range $85.00–$183.00 | — — | — — |
Consensus stance | 52% Buy37% Hold11% Sell | 67% Buy33% Hold0% Sell | 50% Buy0% Hold50% Sell |